nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—PLAU—endothelium—atherosclerosis	0.0168	0.13	CbGeAlD
Amiloride—PLAU—blood vessel—atherosclerosis	0.0155	0.12	CbGeAlD
Amiloride—AOC1—connective tissue—atherosclerosis	0.00873	0.0675	CbGeAlD
Amiloride—SLC9A1—connective tissue—atherosclerosis	0.00836	0.0647	CbGeAlD
Amiloride—PLAU—connective tissue—atherosclerosis	0.00793	0.0613	CbGeAlD
Amiloride—SLC9A1—cardiovascular system—atherosclerosis	0.00727	0.0563	CbGeAlD
Amiloride—Foetor hepaticus—Ezetimibe—atherosclerosis	0.00708	0.0173	CcSEcCtD
Amiloride—PLAU—cardiovascular system—atherosclerosis	0.0069	0.0534	CbGeAlD
Amiloride—Foetor hepaticus—Simvastatin—atherosclerosis	0.00675	0.0165	CcSEcCtD
Amiloride—ASIC1—adipose tissue—atherosclerosis	0.0067	0.0518	CbGeAlD
Amiloride—SLC9A1—adipose tissue—atherosclerosis	0.00641	0.0496	CbGeAlD
Amiloride—Foetor hepaticus—Pravastatin—atherosclerosis	0.00611	0.0149	CcSEcCtD
Amiloride—PLAU—adipose tissue—atherosclerosis	0.00608	0.047	CbGeAlD
Amiloride—Liver disorder—Ezetimibe—atherosclerosis	0.0059	0.0144	CcSEcCtD
Amiloride—SCNN1B—adipose tissue—atherosclerosis	0.00576	0.0446	CbGeAlD
Amiloride—Liver disorder—Simvastatin—atherosclerosis	0.00562	0.0137	CcSEcCtD
Amiloride—SCNN1A—adipose tissue—atherosclerosis	0.00533	0.0412	CbGeAlD
Amiloride—Peptic ulcer—Niacin—atherosclerosis	0.00526	0.0128	CcSEcCtD
Amiloride—Heartburn—Niacin—atherosclerosis	0.00511	0.0125	CcSEcCtD
Amiloride—Liver disorder—Pravastatin—atherosclerosis	0.00508	0.0124	CcSEcCtD
Amiloride—Heartburn—Pravastatin—atherosclerosis	0.00503	0.0123	CcSEcCtD
Amiloride—SCNN1D—liver—atherosclerosis	0.00478	0.037	CbGeAlD
Amiloride—AOC1—liver—atherosclerosis	0.0047	0.0363	CbGeAlD
Amiloride—SLC9A1—liver—atherosclerosis	0.0045	0.0348	CbGeAlD
Amiloride—Gynaecomastia—Rosuvastatin—atherosclerosis	0.00433	0.0105	CcSEcCtD
Amiloride—PLAU—liver—atherosclerosis	0.00426	0.033	CbGeAlD
Amiloride—Neck pain—Ezetimibe—atherosclerosis	0.00407	0.00991	CcSEcCtD
Amiloride—Hepatocellular injury—Ezetimibe—atherosclerosis	0.00402	0.0098	CcSEcCtD
Amiloride—Hepatocellular injury—Simvastatin—atherosclerosis	0.00383	0.00934	CcSEcCtD
Amiloride—Hyperuricaemia—Niacin—atherosclerosis	0.00379	0.00925	CcSEcCtD
Amiloride—SCNN1A—liver—atherosclerosis	0.00374	0.0289	CbGeAlD
Amiloride—Gynaecomastia—Lovastatin—atherosclerosis	0.00367	0.00894	CcSEcCtD
Amiloride—Blood uric acid increased—Niacin—atherosclerosis	0.00358	0.00873	CcSEcCtD
Amiloride—Hepatocellular injury—Pravastatin—atherosclerosis	0.00346	0.00845	CcSEcCtD
Amiloride—Gynaecomastia—Simvastatin—atherosclerosis	0.00343	0.00836	CcSEcCtD
Amiloride—Hepatic function abnormal—Lovastatin—atherosclerosis	0.0034	0.0083	CcSEcCtD
Amiloride—Hepatic function abnormal—Simvastatin—atherosclerosis	0.00318	0.00776	CcSEcCtD
Amiloride—Urine output increased—Niacin—atherosclerosis	0.00318	0.00776	CcSEcCtD
Amiloride—Gynaecomastia—Pravastatin—atherosclerosis	0.0031	0.00756	CcSEcCtD
Amiloride—Muscular weakness—Rosuvastatin—atherosclerosis	0.0031	0.00754	CcSEcCtD
Amiloride—Pain in extremity—Lovastatin—atherosclerosis	0.00297	0.00725	CcSEcCtD
Amiloride—Hepatic function abnormal—Niacin—atherosclerosis	0.00292	0.00712	CcSEcCtD
Amiloride—Pain in extremity—Ezetimibe—atherosclerosis	0.00292	0.00711	CcSEcCtD
Amiloride—Polyuria—Niacin—atherosclerosis	0.00291	0.00709	CcSEcCtD
Amiloride—Hepatic function abnormal—Pravastatin—atherosclerosis	0.00288	0.00701	CcSEcCtD
Amiloride—Depression—Rosuvastatin—atherosclerosis	0.0027	0.00657	CcSEcCtD
Amiloride—Cramp muscle—Lovastatin—atherosclerosis	0.00268	0.00653	CcSEcCtD
Amiloride—Jaundice—Rosuvastatin—atherosclerosis	0.00264	0.00643	CcSEcCtD
Amiloride—Cramp muscle—Ezetimibe—atherosclerosis	0.00263	0.0064	CcSEcCtD
Amiloride—Muscular weakness—Ezetimibe—atherosclerosis	0.00257	0.00627	CcSEcCtD
Amiloride—Gastrointestinal haemorrhage—Niacin—atherosclerosis	0.00255	0.00623	CcSEcCtD
Amiloride—Disturbance in sexual arousal—Niacin—atherosclerosis	0.00253	0.00618	CcSEcCtD
Amiloride—Cramp muscle—Simvastatin—atherosclerosis	0.0025	0.00611	CcSEcCtD
Amiloride—Muscular weakness—Simvastatin—atherosclerosis	0.00245	0.00598	CcSEcCtD
Amiloride—Erectile dysfunction—Lovastatin—atherosclerosis	0.00237	0.00577	CcSEcCtD
Amiloride—Orthostatic hypotension—Niacin—atherosclerosis	0.00233	0.00569	CcSEcCtD
Amiloride—Erectile dysfunction—Ezetimibe—atherosclerosis	0.00232	0.00566	CcSEcCtD
Amiloride—Cramp muscle—Pravastatin—atherosclerosis	0.00226	0.00552	CcSEcCtD
Amiloride—Muscular weakness—Niacin—atherosclerosis	0.00225	0.00549	CcSEcCtD
Amiloride—Abdominal distension—Niacin—atherosclerosis	0.00222	0.00542	CcSEcCtD
Amiloride—Muscular weakness—Pravastatin—atherosclerosis	0.00222	0.00541	CcSEcCtD
Amiloride—Erectile dysfunction—Simvastatin—atherosclerosis	0.00221	0.0054	CcSEcCtD
Amiloride—Jaundice—Ezetimibe—atherosclerosis	0.00219	0.00534	CcSEcCtD
Amiloride—Abdominal distension—Pravastatin—atherosclerosis	0.00219	0.00533	CcSEcCtD
Amiloride—Angina pectoris—Niacin—atherosclerosis	0.00215	0.00524	CcSEcCtD
Amiloride—Depression—Simvastatin—atherosclerosis	0.00214	0.00521	CcSEcCtD
Amiloride—SLC22A4—adipose tissue—atherosclerosis	0.00213	0.0165	CbGeAlD
Amiloride—Angina pectoris—Pravastatin—atherosclerosis	0.00212	0.00516	CcSEcCtD
Amiloride—Jaundice—Simvastatin—atherosclerosis	0.00209	0.00509	CcSEcCtD
Amiloride—Flatulence—Rosuvastatin—atherosclerosis	0.00208	0.00508	CcSEcCtD
Amiloride—Erectile dysfunction—Niacin—atherosclerosis	0.00203	0.00496	CcSEcCtD
Amiloride—Dysuria—Pravastatin—atherosclerosis	0.00203	0.00495	CcSEcCtD
Amiloride—SLC22A1—adipose tissue—atherosclerosis	0.00203	0.0157	CbGeAlD
Amiloride—Erectile dysfunction—Pravastatin—atherosclerosis	0.002	0.00488	CcSEcCtD
Amiloride—Depression—Pravastatin—atherosclerosis	0.00193	0.00471	CcSEcCtD
Amiloride—Jaundice—Niacin—atherosclerosis	0.00192	0.00468	CcSEcCtD
Amiloride—Jaundice—Pravastatin—atherosclerosis	0.00189	0.00461	CcSEcCtD
Amiloride—Cough—Rosuvastatin—atherosclerosis	0.00184	0.0045	CcSEcCtD
Amiloride—Alopecia—Lovastatin—atherosclerosis	0.00182	0.00443	CcSEcCtD
Amiloride—Arthralgia—Rosuvastatin—atherosclerosis	0.0018	0.00439	CcSEcCtD
Amiloride—Alopecia—Ezetimibe—atherosclerosis	0.00178	0.00435	CcSEcCtD
Amiloride—Haemoglobin—Niacin—atherosclerosis	0.00178	0.00433	CcSEcCtD
Amiloride—Haemorrhage—Niacin—atherosclerosis	0.00177	0.00431	CcSEcCtD
Amiloride—Flatulence—Lovastatin—atherosclerosis	0.00176	0.0043	CcSEcCtD
Amiloride—Confusional state—Rosuvastatin—atherosclerosis	0.00174	0.00424	CcSEcCtD
Amiloride—Back pain—Lovastatin—atherosclerosis	0.00173	0.00422	CcSEcCtD
Amiloride—Flatulence—Ezetimibe—atherosclerosis	0.00173	0.00422	CcSEcCtD
Amiloride—Muscle spasms—Lovastatin—atherosclerosis	0.00172	0.0042	CcSEcCtD
Amiloride—Visual impairment—Niacin—atherosclerosis	0.0017	0.00415	CcSEcCtD
Amiloride—Alopecia—Simvastatin—atherosclerosis	0.0017	0.00415	CcSEcCtD
Amiloride—Back pain—Ezetimibe—atherosclerosis	0.0017	0.00414	CcSEcCtD
Amiloride—Muscle spasms—Ezetimibe—atherosclerosis	0.00169	0.00412	CcSEcCtD
Amiloride—Tremor—Lovastatin—atherosclerosis	0.00168	0.00409	CcSEcCtD
Amiloride—Visual impairment—Pravastatin—atherosclerosis	0.00168	0.00409	CcSEcCtD
Amiloride—Flatulence—Simvastatin—atherosclerosis	0.00165	0.00402	CcSEcCtD
Amiloride—Tinnitus—Niacin—atherosclerosis	0.00165	0.00402	CcSEcCtD
Amiloride—Tinnitus—Pravastatin—atherosclerosis	0.00162	0.00395	CcSEcCtD
Amiloride—Muscle spasms—Simvastatin—atherosclerosis	0.00161	0.00393	CcSEcCtD
Amiloride—Vertigo—Lovastatin—atherosclerosis	0.00161	0.00392	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00157	0.00383	CcSEcCtD
Amiloride—Tremor—Simvastatin—atherosclerosis	0.00157	0.00383	CcSEcCtD
Amiloride—Alopecia—Niacin—atherosclerosis	0.00156	0.00381	CcSEcCtD
Amiloride—Insomnia—Rosuvastatin—atherosclerosis	0.00156	0.0038	CcSEcCtD
Amiloride—Palpitations—Ezetimibe—atherosclerosis	0.00155	0.00378	CcSEcCtD
Amiloride—Paraesthesia—Rosuvastatin—atherosclerosis	0.00155	0.00378	CcSEcCtD
Amiloride—Alopecia—Pravastatin—atherosclerosis	0.00154	0.00375	CcSEcCtD
Amiloride—Cough—Ezetimibe—atherosclerosis	0.00153	0.00374	CcSEcCtD
Amiloride—Arthralgia—Lovastatin—atherosclerosis	0.00152	0.00372	CcSEcCtD
Amiloride—Chest pain—Lovastatin—atherosclerosis	0.00152	0.00372	CcSEcCtD
Amiloride—Dyspepsia—Rosuvastatin—atherosclerosis	0.00152	0.0037	CcSEcCtD
Amiloride—Flatulence—Niacin—atherosclerosis	0.00152	0.00369	CcSEcCtD
Amiloride—Tension—Niacin—atherosclerosis	0.00151	0.00368	CcSEcCtD
Amiloride—Vertigo—Simvastatin—atherosclerosis	0.00151	0.00367	CcSEcCtD
Amiloride—Chest pain—Ezetimibe—atherosclerosis	0.0015	0.00365	CcSEcCtD
Amiloride—Arthralgia—Ezetimibe—atherosclerosis	0.0015	0.00365	CcSEcCtD
Amiloride—Nervousness—Niacin—atherosclerosis	0.00149	0.00364	CcSEcCtD
Amiloride—Flatulence—Pravastatin—atherosclerosis	0.00149	0.00364	CcSEcCtD
Amiloride—Tension—Pravastatin—atherosclerosis	0.00149	0.00362	CcSEcCtD
Amiloride—Muscle spasms—Niacin—atherosclerosis	0.00148	0.00361	CcSEcCtD
Amiloride—Pain—Rosuvastatin—atherosclerosis	0.00147	0.0036	CcSEcCtD
Amiloride—Constipation—Rosuvastatin—atherosclerosis	0.00147	0.0036	CcSEcCtD
Amiloride—Confusional state—Lovastatin—atherosclerosis	0.00147	0.00359	CcSEcCtD
Amiloride—Nervousness—Pravastatin—atherosclerosis	0.00147	0.00359	CcSEcCtD
Amiloride—Muscle spasms—Pravastatin—atherosclerosis	0.00146	0.00355	CcSEcCtD
Amiloride—Confusional state—Ezetimibe—atherosclerosis	0.00145	0.00352	CcSEcCtD
Amiloride—Arthralgia—Simvastatin—atherosclerosis	0.00143	0.00348	CcSEcCtD
Amiloride—Chest pain—Simvastatin—atherosclerosis	0.00143	0.00348	CcSEcCtD
Amiloride—SLC22A1—liver—atherosclerosis	0.00142	0.011	CbGeAlD
Amiloride—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00142	0.00346	CcSEcCtD
Amiloride—Tremor—Pravastatin—atherosclerosis	0.00142	0.00346	CcSEcCtD
Amiloride—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00141	0.00344	CcSEcCtD
Amiloride—Anorexia—Lovastatin—atherosclerosis	0.00139	0.0034	CcSEcCtD
Amiloride—Vertigo—Niacin—atherosclerosis	0.00138	0.00337	CcSEcCtD
Amiloride—Confusional state—Simvastatin—atherosclerosis	0.00138	0.00336	CcSEcCtD
Amiloride—Abdominal pain—Rosuvastatin—atherosclerosis	0.00136	0.00332	CcSEcCtD
Amiloride—Vertigo—Pravastatin—atherosclerosis	0.00136	0.00332	CcSEcCtD
Amiloride—Palpitations—Niacin—atherosclerosis	0.00136	0.00331	CcSEcCtD
Amiloride—Cough—Niacin—atherosclerosis	0.00134	0.00327	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00133	0.00325	CcSEcCtD
Amiloride—Insomnia—Lovastatin—atherosclerosis	0.00132	0.00322	CcSEcCtD
Amiloride—Cough—Pravastatin—atherosclerosis	0.00132	0.00322	CcSEcCtD
Amiloride—Paraesthesia—Lovastatin—atherosclerosis	0.00131	0.0032	CcSEcCtD
Amiloride—Arthralgia—Niacin—atherosclerosis	0.00131	0.00319	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00131	0.00318	CcSEcCtD
Amiloride—Anorexia—Simvastatin—atherosclerosis	0.0013	0.00318	CcSEcCtD
Amiloride—Dyspnoea—Lovastatin—atherosclerosis	0.0013	0.00318	CcSEcCtD
Amiloride—Insomnia—Ezetimibe—atherosclerosis	0.0013	0.00316	CcSEcCtD
Amiloride—Chest pain—Pravastatin—atherosclerosis	0.00129	0.00314	CcSEcCtD
Amiloride—Arthralgia—Pravastatin—atherosclerosis	0.00129	0.00314	CcSEcCtD
Amiloride—Paraesthesia—Ezetimibe—atherosclerosis	0.00129	0.00314	CcSEcCtD
Amiloride—Dyspepsia—Lovastatin—atherosclerosis	0.00129	0.00314	CcSEcCtD
Amiloride—Dyspnoea—Ezetimibe—atherosclerosis	0.00128	0.00312	CcSEcCtD
Amiloride—Decreased appetite—Lovastatin—atherosclerosis	0.00127	0.0031	CcSEcCtD
Amiloride—Dyspepsia—Ezetimibe—atherosclerosis	0.00126	0.00308	CcSEcCtD
Amiloride—Fatigue—Lovastatin—atherosclerosis	0.00126	0.00307	CcSEcCtD
Amiloride—Constipation—Lovastatin—atherosclerosis	0.00125	0.00305	CcSEcCtD
Amiloride—Pain—Lovastatin—atherosclerosis	0.00125	0.00305	CcSEcCtD
Amiloride—Confusional state—Pravastatin—atherosclerosis	0.00125	0.00304	CcSEcCtD
Amiloride—Decreased appetite—Ezetimibe—atherosclerosis	0.00125	0.00304	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00125	0.00304	CcSEcCtD
Amiloride—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00124	0.00302	CcSEcCtD
Amiloride—Asthenia—Rosuvastatin—atherosclerosis	0.00124	0.00302	CcSEcCtD
Amiloride—Insomnia—Simvastatin—atherosclerosis	0.00124	0.00301	CcSEcCtD
Amiloride—Fatigue—Ezetimibe—atherosclerosis	0.00124	0.00301	CcSEcCtD
Amiloride—Shock—Niacin—atherosclerosis	0.00124	0.00301	CcSEcCtD
Amiloride—Paraesthesia—Simvastatin—atherosclerosis	0.00123	0.00299	CcSEcCtD
Amiloride—Pain—Ezetimibe—atherosclerosis	0.00123	0.00299	CcSEcCtD
Amiloride—Constipation—Ezetimibe—atherosclerosis	0.00123	0.00299	CcSEcCtD
Amiloride—Pruritus—Rosuvastatin—atherosclerosis	0.00122	0.00297	CcSEcCtD
Amiloride—Dyspnoea—Simvastatin—atherosclerosis	0.00122	0.00297	CcSEcCtD
Amiloride—Feeling abnormal—Lovastatin—atherosclerosis	0.0012	0.00294	CcSEcCtD
Amiloride—Dyspepsia—Simvastatin—atherosclerosis	0.0012	0.00293	CcSEcCtD
Amiloride—Anorexia—Niacin—atherosclerosis	0.0012	0.00292	CcSEcCtD
Amiloride—Gastrointestinal pain—Lovastatin—atherosclerosis	0.0012	0.00291	CcSEcCtD
Amiloride—Decreased appetite—Simvastatin—atherosclerosis	0.00119	0.0029	CcSEcCtD
Amiloride—Feeling abnormal—Ezetimibe—atherosclerosis	0.00118	0.00288	CcSEcCtD
Amiloride—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00118	0.00288	CcSEcCtD
Amiloride—Diarrhoea—Rosuvastatin—atherosclerosis	0.00118	0.00288	CcSEcCtD
Amiloride—Fatigue—Simvastatin—atherosclerosis	0.00118	0.00287	CcSEcCtD
Amiloride—Anorexia—Pravastatin—atherosclerosis	0.00118	0.00287	CcSEcCtD
Amiloride—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00117	0.00286	CcSEcCtD
Amiloride—Constipation—Simvastatin—atherosclerosis	0.00117	0.00285	CcSEcCtD
Amiloride—Pain—Simvastatin—atherosclerosis	0.00117	0.00285	CcSEcCtD
Amiloride—Abdominal pain—Lovastatin—atherosclerosis	0.00116	0.00282	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00114	0.00279	CcSEcCtD
Amiloride—Dizziness—Rosuvastatin—atherosclerosis	0.00114	0.00278	CcSEcCtD
Amiloride—Insomnia—Niacin—atherosclerosis	0.00114	0.00277	CcSEcCtD
Amiloride—Abdominal pain—Ezetimibe—atherosclerosis	0.00113	0.00276	CcSEcCtD
Amiloride—Paraesthesia—Niacin—atherosclerosis	0.00113	0.00275	CcSEcCtD
Amiloride—Feeling abnormal—Simvastatin—atherosclerosis	0.00113	0.00275	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00113	0.00275	CcSEcCtD
Amiloride—Dyspnoea—Niacin—atherosclerosis	0.00112	0.00273	CcSEcCtD
Amiloride—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00112	0.00273	CcSEcCtD
Amiloride—Insomnia—Pravastatin—atherosclerosis	0.00112	0.00273	CcSEcCtD
Amiloride—Somnolence—Niacin—atherosclerosis	0.00112	0.00272	CcSEcCtD
Amiloride—Paraesthesia—Pravastatin—atherosclerosis	0.00111	0.00271	CcSEcCtD
Amiloride—Dyspepsia—Niacin—atherosclerosis	0.00111	0.00269	CcSEcCtD
Amiloride—Dyspnoea—Pravastatin—atherosclerosis	0.0011	0.00269	CcSEcCtD
Amiloride—Decreased appetite—Niacin—atherosclerosis	0.00109	0.00266	CcSEcCtD
Amiloride—Dyspepsia—Pravastatin—atherosclerosis	0.00109	0.00265	CcSEcCtD
Amiloride—Rash—Rosuvastatin—atherosclerosis	0.00109	0.00265	CcSEcCtD
Amiloride—Dermatitis—Rosuvastatin—atherosclerosis	0.00109	0.00265	CcSEcCtD
Amiloride—Gastrointestinal disorder—Niacin—atherosclerosis	0.00108	0.00264	CcSEcCtD
Amiloride—Abdominal pain—Simvastatin—atherosclerosis	0.00108	0.00263	CcSEcCtD
Amiloride—Headache—Rosuvastatin—atherosclerosis	0.00108	0.00263	CcSEcCtD
Amiloride—Decreased appetite—Pravastatin—atherosclerosis	0.00107	0.00262	CcSEcCtD
Amiloride—Pain—Niacin—atherosclerosis	0.00107	0.00262	CcSEcCtD
Amiloride—Fatigue—Pravastatin—atherosclerosis	0.00107	0.0026	CcSEcCtD
Amiloride—Constipation—Pravastatin—atherosclerosis	0.00106	0.00258	CcSEcCtD
Amiloride—Pain—Pravastatin—atherosclerosis	0.00106	0.00258	CcSEcCtD
Amiloride—Asthenia—Lovastatin—atherosclerosis	0.00105	0.00256	CcSEcCtD
Amiloride—Pruritus—Lovastatin—atherosclerosis	0.00103	0.00252	CcSEcCtD
Amiloride—Asthenia—Ezetimibe—atherosclerosis	0.00103	0.00251	CcSEcCtD
Amiloride—Gastrointestinal pain—Niacin—atherosclerosis	0.00103	0.0025	CcSEcCtD
Amiloride—Nausea—Rosuvastatin—atherosclerosis	0.00102	0.0025	CcSEcCtD
Amiloride—Feeling abnormal—Pravastatin—atherosclerosis	0.00102	0.00248	CcSEcCtD
Amiloride—Pruritus—Ezetimibe—atherosclerosis	0.00101	0.00247	CcSEcCtD
Amiloride—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00101	0.00246	CcSEcCtD
Amiloride—Diarrhoea—Lovastatin—atherosclerosis	0.001	0.00244	CcSEcCtD
Amiloride—Abdominal pain—Niacin—atherosclerosis	0.000992	0.00242	CcSEcCtD
Amiloride—Asthenia—Simvastatin—atherosclerosis	0.000981	0.00239	CcSEcCtD
Amiloride—Diarrhoea—Ezetimibe—atherosclerosis	0.000981	0.00239	CcSEcCtD
Amiloride—Abdominal pain—Pravastatin—atherosclerosis	0.000977	0.00238	CcSEcCtD
Amiloride—Pruritus—Simvastatin—atherosclerosis	0.000967	0.00236	CcSEcCtD
Amiloride—Dizziness—Lovastatin—atherosclerosis	0.000967	0.00236	CcSEcCtD
Amiloride—Dizziness—Ezetimibe—atherosclerosis	0.000948	0.00231	CcSEcCtD
Amiloride—Diarrhoea—Simvastatin—atherosclerosis	0.000935	0.00228	CcSEcCtD
Amiloride—Vomiting—Lovastatin—atherosclerosis	0.000929	0.00227	CcSEcCtD
Amiloride—Rash—Lovastatin—atherosclerosis	0.000922	0.00225	CcSEcCtD
Amiloride—Dermatitis—Lovastatin—atherosclerosis	0.000921	0.00224	CcSEcCtD
Amiloride—Headache—Lovastatin—atherosclerosis	0.000916	0.00223	CcSEcCtD
Amiloride—Vomiting—Ezetimibe—atherosclerosis	0.000912	0.00222	CcSEcCtD
Amiloride—Dizziness—Simvastatin—atherosclerosis	0.000904	0.0022	CcSEcCtD
Amiloride—Rash—Ezetimibe—atherosclerosis	0.000904	0.0022	CcSEcCtD
Amiloride—Dermatitis—Ezetimibe—atherosclerosis	0.000903	0.0022	CcSEcCtD
Amiloride—Asthenia—Niacin—atherosclerosis	0.000901	0.0022	CcSEcCtD
Amiloride—Headache—Ezetimibe—atherosclerosis	0.000898	0.00219	CcSEcCtD
Amiloride—Pruritus—Niacin—atherosclerosis	0.000888	0.00217	CcSEcCtD
Amiloride—Asthenia—Pravastatin—atherosclerosis	0.000887	0.00216	CcSEcCtD
Amiloride—Pruritus—Pravastatin—atherosclerosis	0.000875	0.00213	CcSEcCtD
Amiloride—Vomiting—Simvastatin—atherosclerosis	0.000869	0.00212	CcSEcCtD
Amiloride—Nausea—Lovastatin—atherosclerosis	0.000868	0.00212	CcSEcCtD
Amiloride—Rash—Simvastatin—atherosclerosis	0.000862	0.0021	CcSEcCtD
Amiloride—Dermatitis—Simvastatin—atherosclerosis	0.000861	0.0021	CcSEcCtD
Amiloride—Diarrhoea—Niacin—atherosclerosis	0.000859	0.00209	CcSEcCtD
Amiloride—Headache—Simvastatin—atherosclerosis	0.000857	0.00209	CcSEcCtD
Amiloride—Nausea—Ezetimibe—atherosclerosis	0.000852	0.00208	CcSEcCtD
Amiloride—Diarrhoea—Pravastatin—atherosclerosis	0.000846	0.00206	CcSEcCtD
Amiloride—Dizziness—Niacin—atherosclerosis	0.00083	0.00202	CcSEcCtD
Amiloride—Dizziness—Pravastatin—atherosclerosis	0.000817	0.00199	CcSEcCtD
Amiloride—Nausea—Simvastatin—atherosclerosis	0.000812	0.00198	CcSEcCtD
Amiloride—Vomiting—Niacin—atherosclerosis	0.000798	0.00195	CcSEcCtD
Amiloride—Rash—Niacin—atherosclerosis	0.000792	0.00193	CcSEcCtD
Amiloride—Dermatitis—Niacin—atherosclerosis	0.000791	0.00193	CcSEcCtD
Amiloride—Headache—Niacin—atherosclerosis	0.000786	0.00192	CcSEcCtD
Amiloride—Vomiting—Pravastatin—atherosclerosis	0.000786	0.00192	CcSEcCtD
Amiloride—Rash—Pravastatin—atherosclerosis	0.000779	0.0019	CcSEcCtD
Amiloride—Dermatitis—Pravastatin—atherosclerosis	0.000779	0.0019	CcSEcCtD
Amiloride—Headache—Pravastatin—atherosclerosis	0.000774	0.00189	CcSEcCtD
Amiloride—Nausea—Niacin—atherosclerosis	0.000746	0.00182	CcSEcCtD
Amiloride—Nausea—Pravastatin—atherosclerosis	0.000734	0.00179	CcSEcCtD
Amiloride—SCNN1D—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.000312	0.000678	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.000312	0.000678	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.000312	0.000678	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.000312	0.000678	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000309	0.000672	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PLG—atherosclerosis	0.000307	0.000666	CbGpPWpGaD
Amiloride—SLC9A1—Disease—APOA2—atherosclerosis	0.0003	0.000652	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—FABP4—atherosclerosis	0.000298	0.000646	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—LCAT—atherosclerosis	0.000298	0.000646	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—PLG—atherosclerosis	0.000294	0.000639	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—SOD1—atherosclerosis	0.000294	0.000638	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—APOA4—atherosclerosis	0.000292	0.000634	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—AKT1—atherosclerosis	0.000291	0.000633	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP7A1—atherosclerosis	0.000287	0.000623	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IL6—atherosclerosis	0.000285	0.000619	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.00028	0.000609	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—IGF2—atherosclerosis	0.000279	0.000606	CbGpPWpGaD
Amiloride—SLC9A1—Disease—BGN—atherosclerosis	0.000277	0.000602	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.000271	0.00059	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—APOB—atherosclerosis	0.000271	0.000588	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP27A1—atherosclerosis	0.000265	0.000576	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—APOB—atherosclerosis	0.00026	0.000565	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—AKT1—atherosclerosis	0.000255	0.000554	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000252	0.000547	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PRKCG—atherosclerosis	0.000252	0.000546	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PLA2G2A—atherosclerosis	0.000251	0.000546	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—APOA2—atherosclerosis	0.000251	0.000546	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ALOX15—atherosclerosis	0.000251	0.000546	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ALOX5AP—atherosclerosis	0.000251	0.000546	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ABCG5—atherosclerosis	0.000248	0.000539	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—ALB—atherosclerosis	0.000247	0.000537	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—ALB—atherosclerosis	0.000247	0.000537	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—ALB—atherosclerosis	0.000247	0.000537	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—ALB—atherosclerosis	0.000247	0.000537	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—ALB—atherosclerosis	0.000247	0.000537	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—CD36—atherosclerosis	0.000246	0.000534	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000243	0.000527	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CST3—atherosclerosis	0.000242	0.000525	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—LPA—atherosclerosis	0.00024	0.000521	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—BGN—atherosclerosis	0.000232	0.000505	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—APOA5—atherosclerosis	0.00023	0.000499	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NAMPT—atherosclerosis	0.000229	0.000497	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PDGFB—atherosclerosis	0.000227	0.000492	CbGpPWpGaD
Amiloride—SLC9A1—Disease—APOC3—atherosclerosis	0.000226	0.000491	CbGpPWpGaD
Amiloride—SLC9A1—Disease—LDLR—atherosclerosis	0.000225	0.000488	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—MMP1—atherosclerosis	0.000224	0.000487	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PLA2G1B—atherosclerosis	0.000221	0.000481	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—PPARA—atherosclerosis	0.000219	0.000476	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HSPA1B—atherosclerosis	0.000217	0.000471	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—CAV1—atherosclerosis	0.000215	0.000467	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—APOA1—atherosclerosis	0.000214	0.000466	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ALOX5—atherosclerosis	0.000214	0.000464	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NCF1—atherosclerosis	0.00021	0.000457	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.000206	0.000447	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—F2—atherosclerosis	0.000205	0.000444	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—NOS2—atherosclerosis	0.000202	0.000439	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CYBA—atherosclerosis	0.000198	0.000429	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PIK3CG—atherosclerosis	0.000196	0.000425	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PARP1—atherosclerosis	0.000193	0.00042	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000193	0.000419	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—NAMPT—atherosclerosis	0.000192	0.000416	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—LIPC—atherosclerosis	0.000191	0.000414	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—APOC3—atherosclerosis	0.000189	0.000411	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—LDLR—atherosclerosis	0.000188	0.000409	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000185	0.000402	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CETP—atherosclerosis	0.000184	0.000399	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.00018	0.000391	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—CETP—atherosclerosis	0.00018	0.00039	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—IGF1—atherosclerosis	0.000179	0.000389	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—SCARB1—atherosclerosis	0.000176	0.000382	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000172	0.000375	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—SERPINE1—atherosclerosis	0.00017	0.00037	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—ALB—atherosclerosis	0.00017	0.000369	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—HMGCR—atherosclerosis	0.000166	0.000361	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—ALB—atherosclerosis	0.000163	0.000354	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—NOS3—atherosclerosis	0.000162	0.000353	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.000158	0.000344	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ABCA1—atherosclerosis	0.000148	0.000322	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—ALB—atherosclerosis	0.000147	0.000319	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000146	0.000318	CbGpPWpGaD
Amiloride—SLC9A1—Disease—APOB—atherosclerosis	0.000145	0.000316	CbGpPWpGaD
Amiloride—SLC9A1—Disease—LPL—atherosclerosis	0.000139	0.000302	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000136	0.000296	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PRKCG—atherosclerosis	0.000135	0.000293	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—PLG—atherosclerosis	0.000135	0.000292	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000133	0.000288	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—HMOX1—atherosclerosis	0.000127	0.000276	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—PRKCG—atherosclerosis	0.000127	0.000275	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MTHFR—atherosclerosis	0.000125	0.000272	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.000124	0.00027	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000124	0.000268	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—APOB—atherosclerosis	0.000122	0.000264	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PDGFB—atherosclerosis	0.000122	0.000264	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000119	0.000259	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—APOB—atherosclerosis	0.000119	0.000258	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GSTM1—atherosclerosis	0.000118	0.000257	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—PRKCG—atherosclerosis	0.000118	0.000257	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—VEGFA—atherosclerosis	0.000117	0.000254	CbGpPWpGaD
Amiloride—SLC9A1—Disease—APOE—atherosclerosis	0.000116	0.000253	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—LPL—atherosclerosis	0.000116	0.000253	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CAV1—atherosclerosis	0.000115	0.00025	CbGpPWpGaD
Amiloride—SLC9A1—Disease—APOA1—atherosclerosis	0.000115	0.00025	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000115	0.000249	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GPX1—atherosclerosis	0.000113	0.000246	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000111	0.000241	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—MAPK3—atherosclerosis	0.000111	0.00024	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CD36—atherosclerosis	0.000111	0.00024	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NOS2—atherosclerosis	0.000108	0.000236	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—TGFB1—atherosclerosis	0.000107	0.000233	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000107	0.000232	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—LDLRAP1—atherosclerosis	0.000106	0.000231	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—MTHFR—atherosclerosis	0.000105	0.000227	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PPARA—atherosclerosis	0.000103	0.000223	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—PPARA—atherosclerosis	0.0001	0.000218	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PLTP—atherosclerosis	0.0001	0.000217	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—AGT—atherosclerosis	9.95e-05	0.000216	CbGpPWpGaD
Amiloride—SLC9A1—Disease—INS—atherosclerosis	9.94e-05	0.000216	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—LDLRAP1—atherosclerosis	9.91e-05	0.000215	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—APOE—atherosclerosis	9.75e-05	0.000212	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—PRKCG—atherosclerosis	9.72e-05	0.000211	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CAV1—atherosclerosis	9.66e-05	0.00021	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—APOA1—atherosclerosis	9.64e-05	0.000209	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—APOA1—atherosclerosis	9.42e-05	0.000204	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PLTP—atherosclerosis	9.32e-05	0.000202	CbGpPWpGaD
Amiloride—SLC9A1—Disease—SERPINE1—atherosclerosis	9.13e-05	0.000198	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—PRKCG—atherosclerosis	9.06e-05	0.000197	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CG—atherosclerosis	8.8e-05	0.000191	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NOS3—atherosclerosis	8.72e-05	0.000189	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ABCG8—atherosclerosis	8.67e-05	0.000188	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—LTA4H—atherosclerosis	8.67e-05	0.000188	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—CETP—atherosclerosis	8.5e-05	0.000185	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PPARG—atherosclerosis	8.49e-05	0.000184	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—INS—atherosclerosis	8.33e-05	0.000181	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ABCG8—atherosclerosis	8.08e-05	0.000175	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—LTA4H—atherosclerosis	8.08e-05	0.000175	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PTGS2—atherosclerosis	7.98e-05	0.000173	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—CETP—atherosclerosis	7.92e-05	0.000172	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ALB—atherosclerosis	7.64e-05	0.000166	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—PLAT—atherosclerosis	7.49e-05	0.000163	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—AKT1—atherosclerosis	7.47e-05	0.000162	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ALB—atherosclerosis	7.46e-05	0.000162	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—NOS3—atherosclerosis	7.3e-05	0.000159	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—PLAT—atherosclerosis	6.98e-05	0.000152	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—ALB—atherosclerosis	6.94e-05	0.000151	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ABCG1—atherosclerosis	6.85e-05	0.000149	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PTGS2—atherosclerosis	6.68e-05	0.000145	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—ALB—atherosclerosis	6.47e-05	0.000141	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—LCAT—atherosclerosis	6.44e-05	0.00014	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—FABP4—atherosclerosis	6.44e-05	0.00014	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ABCG1—atherosclerosis	6.39e-05	0.000139	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—PLG—atherosclerosis	6.37e-05	0.000138	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—APOA4—atherosclerosis	6.32e-05	0.000137	CbGpPWpGaD
Amiloride—SLC9A1—Disease—STAT3—atherosclerosis	6.22e-05	0.000135	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP7A1—atherosclerosis	6.21e-05	0.000135	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—FABP4—atherosclerosis	6e-05	0.00013	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—LCAT—atherosclerosis	6e-05	0.00013	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MAPK3—atherosclerosis	5.94e-05	0.000129	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—PLG—atherosclerosis	5.93e-05	0.000129	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—APOA4—atherosclerosis	5.89e-05	0.000128	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	5.88e-05	0.000128	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP7A1—atherosclerosis	5.79e-05	0.000126	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TGFB1—atherosclerosis	5.77e-05	0.000125	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP27A1—atherosclerosis	5.74e-05	0.000125	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—APOB—atherosclerosis	5.63e-05	0.000122	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	5.48e-05	0.000119	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALOX5AP—atherosclerosis	5.44e-05	0.000118	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALOX15—atherosclerosis	5.44e-05	0.000118	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PLA2G2A—atherosclerosis	5.44e-05	0.000118	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—APOA2—atherosclerosis	5.44e-05	0.000118	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ABCG5—atherosclerosis	5.38e-05	0.000117	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP27A1—atherosclerosis	5.35e-05	0.000116	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—APOB—atherosclerosis	5.25e-05	0.000114	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—LPA—atherosclerosis	5.19e-05	0.000113	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PLA2G2A—atherosclerosis	5.07e-05	0.00011	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALOX15—atherosclerosis	5.07e-05	0.00011	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—APOA2—atherosclerosis	5.07e-05	0.00011	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALOX5AP—atherosclerosis	5.07e-05	0.00011	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—BGN—atherosclerosis	5.03e-05	0.000109	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ABCG5—atherosclerosis	5.01e-05	0.000109	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—APOA5—atherosclerosis	4.98e-05	0.000108	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—LPA—atherosclerosis	4.84e-05	0.000105	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PLA2G1B—atherosclerosis	4.79e-05	0.000104	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.75e-05	0.000103	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—BGN—atherosclerosis	4.69e-05	0.000102	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—APOA5—atherosclerosis	4.64e-05	0.000101	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALOX5—atherosclerosis	4.63e-05	0.0001	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PLA2G1B—atherosclerosis	4.47e-05	9.7e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—APOA1—atherosclerosis	4.45e-05	9.67e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.42e-05	9.61e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IL6—atherosclerosis	4.35e-05	9.44e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALOX5—atherosclerosis	4.31e-05	9.37e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NAMPT—atherosclerosis	4.15e-05	9.01e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—APOA1—atherosclerosis	4.15e-05	9.01e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—LIPC—atherosclerosis	4.13e-05	8.96e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—APOC3—atherosclerosis	4.1e-05	8.9e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—LDLR—atherosclerosis	4.07e-05	8.85e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—AKT1—atherosclerosis	4.01e-05	8.7e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CETP—atherosclerosis	3.98e-05	8.64e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NAMPT—atherosclerosis	3.87e-05	8.4e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—LIPC—atherosclerosis	3.84e-05	8.35e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—APOC3—atherosclerosis	3.82e-05	8.3e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SCARB1—atherosclerosis	3.81e-05	8.28e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—LDLR—atherosclerosis	3.8e-05	8.25e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CETP—atherosclerosis	3.71e-05	8.05e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HMGCR—atherosclerosis	3.6e-05	7.82e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SCARB1—atherosclerosis	3.55e-05	7.71e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ALB—atherosclerosis	3.53e-05	7.66e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—AKT1—atherosclerosis	3.36e-05	7.29e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HMGCR—atherosclerosis	3.35e-05	7.28e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ALB—atherosclerosis	3.29e-05	7.14e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ABCA1—atherosclerosis	3.21e-05	6.97e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ABCA1—atherosclerosis	2.99e-05	6.49e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HMOX1—atherosclerosis	2.75e-05	5.98e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—APOB—atherosclerosis	2.64e-05	5.72e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HMOX1—atherosclerosis	2.57e-05	5.57e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTM1—atherosclerosis	2.56e-05	5.57e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—LPL—atherosclerosis	2.52e-05	5.47e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—APOB—atherosclerosis	2.46e-05	5.34e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GPX1—atherosclerosis	2.46e-05	5.33e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CD36—atherosclerosis	2.39e-05	5.19e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTM1—atherosclerosis	2.39e-05	5.19e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—LPL—atherosclerosis	2.35e-05	5.09e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GPX1—atherosclerosis	2.29e-05	4.97e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MTHFR—atherosclerosis	2.27e-05	4.92e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CD36—atherosclerosis	2.23e-05	4.84e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PPARA—atherosclerosis	2.22e-05	4.83e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AGT—atherosclerosis	2.15e-05	4.68e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MTHFR—atherosclerosis	2.11e-05	4.59e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—APOE—atherosclerosis	2.11e-05	4.58e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CAV1—atherosclerosis	2.09e-05	4.54e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—APOA1—atherosclerosis	2.09e-05	4.53e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PPARA—atherosclerosis	2.07e-05	4.5e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AGT—atherosclerosis	2.01e-05	4.36e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—APOE—atherosclerosis	1.97e-05	4.27e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CAV1—atherosclerosis	1.95e-05	4.23e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—APOA1—atherosclerosis	1.94e-05	4.22e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CG—atherosclerosis	1.9e-05	4.13e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PPARG—atherosclerosis	1.84e-05	3.99e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—INS—atherosclerosis	1.8e-05	3.91e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CG—atherosclerosis	1.77e-05	3.85e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PPARG—atherosclerosis	1.71e-05	3.72e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—INS—atherosclerosis	1.68e-05	3.65e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALB—atherosclerosis	1.65e-05	3.59e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NOS3—atherosclerosis	1.58e-05	3.43e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALB—atherosclerosis	1.54e-05	3.34e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NOS3—atherosclerosis	1.47e-05	3.2e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTGS2—atherosclerosis	1.45e-05	3.14e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTGS2—atherosclerosis	1.35e-05	2.93e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AKT1—atherosclerosis	7.27e-06	1.58e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AKT1—atherosclerosis	6.77e-06	1.47e-05	CbGpPWpGaD
